1. Home
  2. APGE vs OBDC Comparison

APGE vs OBDC Comparison

Compare APGE & OBDC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Apogee Therapeutics Inc.

APGE

Apogee Therapeutics Inc.

HOLD

Current Price

$134.08

Market Cap

4.7B

Sector

Health Care

ML Signal

HOLD

Logo Blue Owl Capital Corporation

OBDC

Blue Owl Capital Corporation

HOLD

Current Price

$10.81

Market Cap

5.6B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
APGE
OBDC
Founded
2022
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
4.7B
5.6B
IPO Year
2023
2015

Fundamental Metrics

Financial Performance
Metric
APGE
OBDC
Price
$134.08
$10.81
Analyst Decision
Strong Buy
Buy
Analyst Count
13
8
Target Price
$109.67
$14.00
AVG Volume (30 Days)
5.4M
3.8M
Earning Date
05-12-2026
05-06-2026
Dividend Yield
N/A
13.40%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$34.34
$10.52
52 Week High
$134.35
$14.85

Technical Indicators

Market Signals
Indicator
APGE
OBDC
Relative Strength Index (RSI) 80.75 44.60
Support Level $80.52 $10.62
Resistance Level N/A $11.27
Average True Range (ATR) 0.43 0.22
MACD -1.69 0.01
Stochastic Oscillator 86.53 18.55

Price Performance

Historical Comparison
APGE
OBDC

About APGE Apogee Therapeutics Inc.

Apogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications. . Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.

About OBDC Blue Owl Capital Corporation

Blue Owl Capital Corp is a specialty finance company and business development company (BDC) focused on providing direct lending solutions to U.S. middle-market companies. The company seeks to generate current income and, to a lesser extent, capital appreciation by targeting investment opportunities with favorable risk-adjusted returns, including senior secured, subordinated, or mezzanine loans and equity-related instruments. Its investment strategies are intended to generate favorable returns across credit cycles with an emphasis on preserving capital.

Share on Social Networks: